?????I'll tell you one thing, the more I try to DYOD on this one, the more confused I become — and this board doesn't help much (respectfully). I can't tell where PMN plans to get their money, or if they have anything to sell (besides research results) — are they selling intellectual property, by way of therepeutics, or are they selling development IP? Are they planning clinincal trials or just more white papers?
Regardless, it hasn't stopped insiders from buying at a very vigorous rate — that's the intriging part.
Can anyone provide some baseline bullets, or an elevator pitch for PMN?